Quest Wins First Commercial Zika Test FDA Emergency-Use Approval
This article was originally published in The Gray Sheet
Executive Summary
FDA approved the first emergency-use authorization for a commercially developed, molecular-based Zika virus diagnostics, developed by Quest's Focus Diagnostics subsidiary.